Sahajanand Medical IPO Day 1: GMP ₹40
Welcome back, IPO enthusiasts! Today marks the commencement of Sahajanand Medical’s mainboard IPO journey on the NSE, and as expected for Day 1, the subscription books have just opened. It’s still very early days, and we’re looking at zero subscriptions across all categories – Retail, NII, and QIB. This is standard for the first day, as most investors prefer to wait and observe the initial traction before committing their capital. The IPO is open for subscription from October 15th to October 19th, 2026, so there’s ample time for things to heat up.
| Date | GMP | Est. Listing |
|---|---|---|
| 22 Oct | +₹18 | ₹362 |
| 21 Oct | +₹22 | ₹366 |
| 20 Oct | +₹25 | ₹369 |
| 19 Oct | +₹23 | ₹367 |
| 18 Oct | +₹28 | ₹372 |
Subscription Status
As of the end of Day 1, Sahajanand Medical IPO is showing 0x subscriptions across the board. This is not a cause for alarm at this stage. Typically, the first day of an IPO sees minimal activity. Retail investors, who usually form a significant portion of the demand, often wait until the last couple of days to apply. Similarly, High Net-worth Individuals (HNIs) and Qualified Institutional Buyers (QIBs) tend to assess the market sentiment and overall subscription levels before making their move. The lack of early subscription numbers simply means the market is taking its time to digest the offering. We’ll be keeping a close eye on how these numbers evolve over the next few days, particularly as we approach the closing date.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 3.04x | |
| NII / HNI | 14.64x | |
| QIB | 34.70x | |
| Total | 34.70x |
GMP Update
Now, let’s talk Grey Market Premium (GMP). Sahajanand Medical IPO’s GMP is currently standing firm at ₹40. Interestingly, this is unchanged from yesterday’s ₹40. A steady GMP of ₹40 suggests that the market sentiment towards this IPO remains cautiously optimistic. At an issue price of ₹344, a GMP of ₹40 translates to an estimated listing price of ₹384 (Issue Price + GMP). This projected listing price is a good ₹40 above the issue price, indicating a potential listing gain of approximately 11.6%. While a stable GMP is encouraging, it’s important to remember that GMP is an unofficial indicator and can fluctuate significantly. It’s a useful gauge of market interest, but it’s not a guarantee of listing performance.
Should You Apply?
So, the big question: should you be throwing your hat in the ring for Sahajanand Medical’s IPO just yet? Based on Day 1’s subscription data, it’s too early to make a definitive call. The zero subscription numbers are perfectly normal for this stage. However, the consistent GMP of ₹40 provides a positive signal, hinting at potential listing gains. The lot size is 43 shares, meaning an investment of ₹14,792 per lot (43 shares * ₹344 issue price). For those considering applying, it’s wise to wait and observe the subscription momentum in the coming days. Keep an eye on the retail portion as it starts to fill up, as this often indicates strong retail interest. Remember, SEBI advisors always recommend thorough research and understanding your risk appetite before investing. The IPO period runs until October 19th, 2026, giving you plenty of time to make an informed decision. Don’t rush in on the first day; let the market tell its story.